Dépôt numérique

Inhibition of placental 11beta-hydroxysteroid dehydrogenase type 2 by lead

St-Pierre, Joey; Fraser, Marc et Vaillancourt, Cathy (2016). Inhibition of placental 11beta-hydroxysteroid dehydrogenase type 2 by lead Reproductive Toxicology , vol. 65 . pp. 133-138. DOI: 10.1016/j.reprotox.2016.06.014.

Ce document n'est pas hébergé sur EspaceINRS.


Lead interferes with cortisol blood concentration, increases the risk of obstetrical complications, and could alter fetal development. The placenta controls maternal cortisol transfer to the fetus by the activity of the type 2 11β-hydroxysteroid dehydrogenase (11β-HSD2), which converts cortisol into inactive cortisone. This study determines the effect of lead on the expression and activity of the placental 11β-HSD2 in human trophoblast-like BeWo cells. Cells were treated with increasing concentration (0–1000 nM) of PbCl2 for 24 h. 11β-HSD2 protein expression was reduced by 45% at 1000 nM of PbCl2 compared to untreated cells, while the activity was significantly reduced by PbCl2 at 10, 100 and 1000 nM. This study shows the direct inhibitory action of lead on placental 11β-HSD2 activity and suggests that this heavy metal reduces the efficiency of the placental protection against the adverse effects of high cortisol level during fetal development.

Type de document: Article
Mots-clés libres: BeWo cell; Cortisol; Heavy metal; Human; Stress; Trophoblast
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 30 mai 2017 19:49
Dernière modification: 30 mai 2017 19:49
URI: https://espace.inrs.ca/id/eprint/4588

Gestion Actions (Identification requise)

Modifier la notice Modifier la notice